Drug application
OMECLAMOX-PAK (AMOXICILLIN, CLARITHROMYCIN, OMEPRAZOLE)
Drugs@FDA NDA 050824 · CUMBERLAND
Key facts
| Drug name | OMECLAMOX-PAK |
|---|---|
| Active ingredients | AMOXICILLIN, CLARITHROMYCIN, OMEPRAZOLE |
| Application type | NDA |
| Application number | 050824 |
| Company | CUMBERLAND |
| Dosage forms | CAPSULE, TABLET, CAPSULE, DELAYED RELEASE, ORAL |
| Strength | 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Feb 8, 2011 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: